The Ovarian Cancer Commitment (OCC), established by the European Society of Gynaecological Oncology (ESGO), the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe), and AstraZeneca, is a bold initiative aiming to improve the experience and survival of women living with ovarian cancer.